Iowa House Bill HF330

Iowa 2025-2026 Regular Session

• Introduced: 2/11/25
• Engrossed: 2/20/25
• Refer: 2/24/25
• Enrolled: 5/19/25
• Passed: 6/11/25

Caption

A bill for an act relating to insurance coverage for covered individuals for the treatment of autism spectrum disorder and including applicability provisions. (Formerly HF 5.) Effective date: 07/01/2025. Applicability date: 01/01/2026.

Summary

House File 330 updates Iowa’s insurance coverage laws for autism spectrum disorder by renaming references from “autistic disorders” to “autism spectrum disorder” and aligning the statutory definition with the most recent Diagnostic and Statistical Manual of Mental Disorders. The bill requires covered group health policies, contracts, and plans to provide benefits for diagnosis and treatment of autism spectrum disorder, and it specifically bars aggregate annual or lifetime benefit caps for autism spectrum disorder coverage under the biologically based mental illness mandate. The bill also preserves and clarifies coverage standards for autism-related services. It maintains minimum coverage levels for inpatient and outpatient care, prohibits limits on the number of outpatient visits for applied behavior analysis and autism service provider treatment, and allows deductibles, coinsurance, and copayments only on the same terms as comparable medical benefits. For state employee plans and certain public employee plans, the bill continues required coverage for diagnostic assessment and treatment, keeps the annual maximum benefit framework for some state-plan autism coverage, and ties future adjustments to inflation using the consumer price index. It also coordinates autism coverage under the separate autism treatment statutes so the provisions work together rather than overlap inconsistently.

Impact

HF 330 amends Iowa Code sections 514C.22, 514C.28, and 514C.31, affecting mandated health insurance benefits for autism spectrum disorder across private group policies and certain public employee health plans. It removes outdated terminology, updates the diagnostic reference standard, eliminates aggregate annual and lifetime limits for autism spectrum disorder coverage under the biologically based mental illness provisions, and preserves visit-based coverage protections for applied behavior analysis and related treatment. The bill applies to policies and plans issued, delivered, continued, or renewed on or after January 1, 2026, with the act effective July 1, 2025.

Sentiment

The bill appears to have broad bipartisan support and little visible opposition. It passed the House 92-0 and the Senate 44-0, and the Senate Commerce report was also unanimous at 20-0. The vote history suggests the measure was viewed as a consensus update to existing autism insurance mandates rather than a controversial policy change.

Contention

There is no recorded committee transcript or floor debate in the provided materials, and the unanimous votes indicate no major public contention in the legislative record supplied. The main policy distinctions in the bill are technical but meaningful: it expands and clarifies autism coverage protections while preserving some existing benefit structures for state and public employee plans. Any potential point of concern would likely center on insurance cost and mandate scope, but no legislator or stakeholder opposition is reflected in the available history.